这是一篇来自已证抗体库的有关大鼠 Pdk1的综述,是根据8篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Pdk1 抗体。
Pdk1 同义词: pyruvate dehydrogenase kinase, isozyme 1; PDH kinase 1; PDK p48; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial; pyruvate dehydrogenase kinase, isoenzyme 1

艾博抗(上海)贸易有限公司
兔 单克隆(EPR19573)
  • 免疫印迹; 人类; 1:1000; 图 6c
艾博抗(上海)贸易有限公司 Pdk1抗体(Abcam, ab207450)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 6c). J Transl Med (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 6
艾博抗(上海)贸易有限公司 Pdk1抗体(Abcam, ab90444)被用于被用于免疫印迹在小鼠样品上 (图 6). Am J Physiol Endocrinol Metab (2017) ncbi
小鼠 单克隆(4A11)
  • 免疫组化; 人类; 1:500; 图 1
艾博抗(上海)贸易有限公司 Pdk1抗体(Abcam, ab110025)被用于被用于免疫组化在人类样品上浓度为1:500 (图 1). J Pathol (2015) ncbi
小鼠 单克隆(4A11)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 Pdk1抗体(Abcam, ab110025)被用于被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2013) ncbi
赛信通(上海)生物试剂有限公司
兔 单克隆(C47H1)
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Pdk1抗体(Cell Signaling, 3820)被用于被用于其他在人类样品上 (图 4c). Cancer Cell (2018) ncbi
兔 单克隆(C47H1)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Pdk1抗体(Cell signaling, 3820)被用于被用于免疫印迹在人类样品上 (图 1). Nature (2016) ncbi
兔 单克隆(C47H1)
  • 免疫印迹; 人类; 1:1000; 图 4g
  • 免疫印迹; 小鼠; 1:1000; 图 6l
赛信通(上海)生物试剂有限公司 Pdk1抗体(Cell Signaling Technology, 3820)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 4g) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 6l). FASEB J (2016) ncbi
兔 单克隆(C47H1)
  • 免疫印迹; 牛; 图 1d
赛信通(上海)生物试剂有限公司 Pdk1抗体(Cell Signaling, C47H1)被用于被用于免疫印迹在牛样品上 (图 1d). Oncogene (2014) ncbi
文章列表
  1. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  2. Santacatterina F, Sánchez Aragó M, Catalán García M, Garrabou G, de Arenas C, Grau J, et al. Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis. J Transl Med. 2017;15:29 pubmed 出版商
  3. Gudiksen A, Bertholdt L, Vingborg M, Hansen H, Ringholm S, Pilegaard H. Muscle interleukin-6 and fasting-induced PDH regulation in mouse skeletal muscle. Am J Physiol Endocrinol Metab. 2017;312:E204-E214 pubmed 出版商
  4. Jiang L, Shestov A, Swain P, Yang C, Parker S, Wang Q, et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature. 2016;532:255-8 pubmed 出版商
  5. Sharma B, Kolhe R, Black S, Keller J, Mivechi N, Satyanarayana A. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. FASEB J. 2016;30:262-75 pubmed 出版商
  6. Pértega Gomes N, Felisbino S, Massie C, Vizcaíno J, Coelho R, Sandi C, et al. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. J Pathol. 2015;236:517-30 pubmed 出版商
  7. Medjkane S, Perichon M, Marsolier J, Dairou J, Weitzman J. Theileria induces oxidative stress and HIF1? activation that are essential for host leukocyte transformation. Oncogene. 2014;33:1809-17 pubmed 出版商
  8. Gammon L, Biddle A, Heywood H, Johannessen A, Mackenzie I. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS ONE. 2013;8:e62493 pubmed 出版商